Journal of Clinical Oncology
Lippincott Williams & Wilkins · US · ISSN 0732183X
SJR Q1
What the numbers say
Publication volume is high while citation influence is steady.
Annual output went from 8,174 to 8,705 papers. If you need rapid visibility, expect many contemporaneous articles to compete for attention. Field-weighted citation impact moved from 1.06 to 1.06. Do not expect a change in average citedness from recent trends. The share of top-10% cited papers moved from 6.9% to 7.7%. Exceptional papers can still stand out, though they remain a small minority. Recent titles increasingly carry cancer · ctdna · metastatic. If your manuscript emphasizes those terms, it may match current topical interest.
Citation metrics
SJR quartile
Q1
SJR score
4.65
Citations / doc (2y)
6.24
h-index
736
Based on the Scopus and OpenAlex citation graphs. We do not provide Clarivate’s JCR Impact Factor.
Output and citation impact
Whether citation performance keeps up as output grows.
PapersField-weighted impact
2018
8,174
1.06
2019
7,574
1.19
2020
7,813
0.93
2021
6,486
1.15
2022
7,609
1.18
2023
8,020
1.43
2024
8,194
1.20
2025
8,705
1.06
Topic shift
Share in the last 24 months (2024-09 – 2026-08) versus the previous 24 (2022-09 – 2024-08).
Rising
- HER2/EGFR in Cancer Research0.0%→4.4%+4.4%pPrevNow
- Multiple Myeloma Research and Treatments0.0%→2.8%+2.8%pPrevNow
Falling
- Breast Cancer Treatment Studies2.9%→0.0%−2.9%pPrevNow
- Cancer Treatment and Pharmacology2.5%→0.0%−2.5%pPrevNow
Terms appearing more often
Wording in recent paper titles that stands out against the journal's own baseline.
cancerctdnametastatic
Author countries
Last 24 months (2024-09 – 2026-08) against the previous 24 (2022-09 – 2024-08).
- US53.6%→55.6%+1.9%pPrevNow
- CN13.1%→13.9%+0.8%pPrevNow
- GB6.2%→5.8%−0.5%pPrevNow
- JP5.5%→5.2%−0.3%pPrevNow
- CA5.6%→5.1%−0.5%pPrevNow
- IT5.1%→4.9%−0.1%pPrevNow
Top 5 institutions
Top 5 institutions publishing in this journal, 2018 – 2026.
- Harvard University2,439
- Cornell University1,720
Recently published
20The 20 most recent papers — not the full list.
1
Article2026
Donor Selection and Human Leukocyte Antigen Loss Leukemia Relapse After Hematopoietic Cell TransplantationKatharina Fleischhauer, Cristina Toffalori, Federica Cugnata, Jan A. Hofmann, G Orofino, Francesca Lorentino, Müberra Ahci-Hanci, Vinzenz Lange, Carlheinz Müller, Desireé Kunadt, Martin Bornhäuser, Guillermo Sanz, Robert J. Soiffer, Miguel Waterhouse, Luisa Giaccone, Haris Ali, Kathrin Nachtkamp, Andrea Bacigalupo, Francesca Bonifazi, Leo Luznik, Luca Facchini, Stéfania Bramanti, Arnon Nagler, Riccardo Saccardi, Filippo Milano, Francesco Zallio, Antonio Pierini, Mohamad Mohty, Neal Flomenberg, Akifumi Takaori‐Kondo, Norbert Vey, Takanori Teshima, Nicolaus Kröger, Carolina Martínez Laperche, Marco Andreani, Maria Teresa Lupo Stanghellini, Jacopo Peccatori, Clelia Di Serio, Guido Kobbe, Monzr M. Al Malki, Benedetto Bruno, Robert Zeiser, R. Coleman Lindsley, Jaime Sanz, Dietrich W. Beelen, Friedrich Stölzel, Jürgen Sauter, Alexander H. Schmidt, Fabio Ciceri, Luca Vago, Juan Montoro, Max Jan, Claudia Wehr, Alessandro Busca, Ketevan Gendzekhadze, Esther Schuler, Kathrin Putke, Monica Zanussi, Benedetta Mazzi, Pietro Crivello, Luisa Betke, Esteban Arrieta‐Bolaños, Amin T. Turki, Alessandra Picardi, Mi Kwon, Francis Ayuk, Masahiro Onozawa, Raynier Devillier, Junya Kanda, Dolores Grosso, Florent Malard, Loredana Ruggeri, Heidi Altmann, Esperanza Such, Jerome Ritz, Ralph Wäsch, Lucia Brunello, Shukaib Arslan, Ron Patrick Cadeddu, Massimo Pini, Brandon Hadland, Giovanni Rombolà, Ivetta Danylesko, Daniele Mannina, Annalisa Imovilli, Ivana Gojo, Margherita Ursi, Patrizia Chiusolo, Raffaella Cerretti, Ismael Buño, Anita Badbaran, Hideki Goto, Didier Blaise, Mizuki Watanabe, Zixuan Wang, Éolia Brissot, Alessandra Carotti, Giulio Caravagna
HematologyMedicine
2
Article2026
EXTENDing the Role of Radiation in Oligometastatic DiseaseVivian Tan, David A. Palma
Radiology, Nuclear Medicine and ImagingMedicine
3
Article2026
Early toxicity–driven dose modification and efficacy of adjuvant abemaciclib in high-risk HR+/HER2− early breast cancer: A real-world study in Chinese patients.Jing Huang, Xinyue Ma, Jiao Yang, Jin Yang, Danfeng Dong
Pulmonary and Respiratory MedicineMedicine
4
Article2026
Ultra-specific high-multiplex PCR liquid biopsy assays to enable high-frequency treatment and disease monitoring in urothelial malignancies.Ilan Leibovitch, Asa Eitan, Adi Telem, Inbal Itzhak, Shani Lavi, Ortal Cohen, Alon Shalev
SurgeryMedicine
5
Article2026
Efficacy and safety of first-line modified docetaxel, cisplatin, and fluorouracil (mDCF) in advanced esophageal cancer: A retrospective study from Viet Nam.Hong Thi Anh Can, Giang Nguyen Thi Huong, Dung Xuan Tran, Giap Ngoc Hoang
SurgeryMedicine
6
Article2026
Tofacitinib for immune-related adverse events ≥ grade 3 induced by immune checkpoint inhibitors: A single-arm, open-label, two-stage study.J Y Lin, Yuping Lu, Huishan Zhang, P C. Chen, Dingyi Wang, Yu Chen
OAOncologyMedicine
7
Article2026
Divergence between expected and observed national cancer mortality after the COVID-19 pandemic: A population-based analysis.M. Y. Soomro, Hala Soomro
OncologyMedicine
8
Article2026
Prognostic significance of undetectable baseline HPV circulating tumor DNA in oropharyngeal cancer.Justin Albert Fortino, Aatish Sunder, Rex Lee, Alexander Qian, Alain P. Algazi, Hyunseok Kang, Michael Chow, Mary Jue Xu, Katherine Carolyn Wai, William Ryan, Patrick Ha, Sue S. Yom, Jason Chan
Cancer ResearchBiochemistry, Genetics and Molecular Biology
9
Article2026
Automated tumor content analysis from whole slide images using deep learning models for NGS quality control in precision oncology.Satya Prakash Khuntia, Hitesh Goswami, Kshitij Rishi, Shefali Karve, Puneet Pantane, Prabakar Sampath, Anjali Kulkarni, Praveen Kumar Jha
Cancer ResearchBiochemistry, Genetics and Molecular Biology
10
Article2026
Prognostic role of mismatch repair status in stage II colon cancer at Ho Chi Minh City Oncology Hospital.Quy Nguyen, Đức Phan Thị Hồng, Nhu Ngoc Nguyen Pham
Pathology and Forensic MedicineMedicine
11
12
Article2026
Addressing radiologist inter-reader variability in gastric cancer T staging: A prospective study using the dual-module AI model, TRACE.Chun Yang, Jing Zhang, Y Zhao, Xiaoyun Chai, Zishuo Yan, Jia Wei, Guoliang Zheng
Radiology, Nuclear Medicine and ImagingMedicine
13
Article2026
Integrated analysis of miRNA–mRNA regulatory crosstalk: Insights from the miR-296-3p and DDHD2 network in breast cancer.Ruqia Mehmood Baig, Nafeesa Kainat, Isha Rubab, Rashida Khan, Muqaddus Abbasi
Cancer ResearchBiochemistry, Genetics and Molecular Biology
14
Article2026
TGFβ-mediated overexpression of podoplanin serves as a potential diagnostic biomarker in acute promyelocytic leukemia.Syed Mojiz Hasan, Akash Maity
OncologyMedicine
15
Article2026
Lactate metabolic reprogramming based on LOX/LDHi-Cu NP to enhance copper death in hepatocellular carcinoma cells.Li J, S D Wang
Biomedical EngineeringEngineering
16
Article2026
TP53–EGFR co-mutation landscape in Indian NSCLC: Decoding the genomic blueprint for targeted therapeutic decisions.Vasanthkumar Muthukumar, Vijayalakshmi Ramshankar, Deepika Dash, S Ramalingam Suresh, Yasasve Madhavan, K. Mehanathan, Venkatraman Radhakrishnan, Pragadeesh Thamaraiselvan
Pulmonary and Respiratory MedicineMedicine
17
Article2026
Prospective study of quantitative broadband diffuse optical spectroscopy for differential diagnosis of suspicious breast lesions.Alice M. Police, Roy Stillwell, Christopher Campbell, Alicia Wei, Ola Abdalsalam, Ana Flavia de Almeida Barreto
Radiology, Nuclear Medicine and ImagingMedicine
18
Article2026
A retro-prospective study to determine the patterns of recurrence in gastric and GE junction cancers after curative intent treatment at a tertiary cancer centre of North India.Abrar Rasool Khanday, Nisar Ahmad Syed, Hussain Mohmad Mir, Faisal Guru, Ajas Ibrahim
OAPulmonary and Respiratory MedicineMedicine
19
Article2026
Questioning the benefit of adjuvant chemotherapy in premenopausal HR+/HER2– early breast cancer: Real-world evidence from an Asian cohort.Jen-Yu Chuang, Yuan‐Ching Chang
Cancer ResearchBiochemistry, Genetics and Molecular Biology
20
Article2026
Neoadjuvant chemotherapy plus serplulimab and immuno-response molecular subtype for pMMR locally advanced rectal cancer (FIRM).Tingyu Wu, Jingsong Liu, Wenbo Tang, Wei Shen, Zhongchuan Wang, Liu Y, W Chen, Honghua Jiang, Hui Zhou, Jiwei Sun, W Ding, Jihong Fu, Zhonglin Liang, Tong Yu, Jinglue Song, Weimin Xu, Long Cui, Chenying Liu, Peng Du
OAOncologyMedicine
Most cited
20Top 20 most cited, 2018 – 2026.
1
ArticleCitations 3,6162018
Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice GuidelineJulie R. Brahmer*, Christina Lacchetti, Bryan J. Schneider, Michael B. Atkins, Kelly Brassil, Jeffrey M. Caterino, Ian Chau, Marc S. Ernstoff, Jennifer M. Gardner, Pamela Ginex, Sigrun Hallmeyer, Jennifer Holter Chakrabarty, Natasha B. Leighl, Jennifer S. Mammen, David F. McDermott, Aung Naing, Loretta J. Nastoupil, Tanyanika Phillips, Laura Porter, Igor Puzanov, Cristina Reichner, Bianca Santomasso, Carole Seigel, Alexander I. Spira, María E. Suarez‐Almazor, Yinghong Wang, Jeffrey S. Weber, Jedd D. Wolchok, John A. Thompson
OAOncologyMedicine
2
ArticleCitations 2,9632019
Efficacy of Pembrolizumab in Patients With Noncolorectal High Microsatellite Instability/Mismatch Repair–Deficient Cancer: Results From the Phase II KEYNOTE-158 StudyAurélien Marabelle, Dung T. Le, Paolo A. Ascierto, Anna Maria Di Giacomo, Ana De Jesus‐Acosta, Jean-Pierre Delord, Ravit Geva, Maya Gottfried, Nicolas Penel, Aaron R. Hansen, Sarina A. Piha‐Paul, Toshihiko Doi, Bo Gao, Hyun Cheol Chung, José A. López-Martín, Yung-Jue Bang, Ronnie Shapira Frommer, Manisha H. Shah, Razi Ghori, Andrew K. Joe, Scott K. Pruitt, Luis A. Díaz
OAPathology and Forensic MedicineMedicine
3
ArticleCitations 2,4542018
Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Focused UpdateAntonio C. Wolff, M. Elizabeth Hammond, Kimberly H. Allison, Brittany Harvey, Pamela B. Mangu, John M.S. Bartlett, Michael Bilous, Ian O. Ellis, Patrick L. Fitzgibbons, Wedad Hanna, Robert B. Jenkins, Michael F. Press, Patricia A. Spears, Gail H. Vance, Giuseppe Viale, Lisa M. McShane, Mitch Dowsett
OAOncologyMedicine
4
ArticleCitations 2,0702018
Durable Clinical Benefit With Nivolumab Plus Ipilimumab in DNA Mismatch Repair–Deficient/Microsatellite Instability–High Metastatic Colorectal CancerMichael J. Overman, Sara Lonardi, Ka Yeung Mark Wong, Heinz‐Josef Lenz, Fabio Gelsomino, Massimo Aglietta, Michael A. Morse, Eric Van Cutsem, Ray McDermott, Andrew Hill, Michael B. Sawyer, Alain Hendlisz, Bart Neyns, Magali Svrcek, Rebecca A. Moss, Jean-Marie Ledeine, Z. Alexander Cao, Shital Kamble, Scott Kopetz, Thierry André
OAOncologyMedicine
5
ArticleCitations 1,9642021
Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: ASCO Guideline UpdateBryan J. Schneider, Jarushka Naidoo, Bianca D. Santomasso, Christina Lacchetti, Sherry Adkins, Milan Anadkat, Michael B. Atkins, Kelly J. Brassil, Jeffrey M. Caterino, Ian Chau, Marianne J. Davies, Marc S. Ernstoff, Leslie Fecher, Monalisa Ghosh, Ishmael Jaiyesimi, Jennifer S. Mammen, Aung Naing, Loretta J. Nastoupil, Tanyanika Phillips, Laura D. Porter, Cristina A. Reichner, Carole Seigel, Jung-Min Song, Alexander Spira, Maria Suarez-Almazor, Umang Swami, John A. Thompson, Praveen Vikas, Yinghong Wang, Jeffrey S. Weber, Pauline Funchain, Kathryn Bollin
OAOncologyMedicine
6
ArticleCitations 1,8192019
Pembrolizumab As Second-Line Therapy in Patients With Advanced Hepatocellular Carcinoma in KEYNOTE-240: A Randomized, Double-Blind, Phase III TrialRichard S. Finn, Baek‐Yeol Ryoo, Philippe Merle, Masatoshi Kudo, Mohamed Bouattour, Ho Yeong Lim, В. В. Бредер, Julien Edeline, Yee Chao, Sadahisa Ogasawara, Thomas Yau, Marcelo Garrido, Stephen L. Chan, Jennifer J. Knox, Bruno Daniele, Scot Ebbinghaus, Erluo Chen, Abby B. Siegel, Andrew X. Zhu, Ann‐Lii Cheng, on behalf of the KEYNOTE-240 investigators
HepatologyMedicine
7
ArticleCitations 1,7162019
Updated Analysis of KEYNOTE-024: Pembrolizumab Versus Platinum-Based Chemotherapy for Advanced Non–Small-Cell Lung Cancer With PD-L1 Tumor Proportion Score of 50% or GreaterMartin Reck, Delvys Rodríguez‐Abreu, Andrew Robinson, Rina Hui, Tibor Csőszi, Andrea Fülöp, Maya Gottfried, Nir Peled, Ali Tafreshi, Sinéad Cuffe, Mary O’ Brien, Suman Rao, Katsuyuki Hotta, Kristel Vandormael, Antonio Riccio, Jing Yang, M. Catherine Pietanza, Julie R. Brahmer
OAOncologyMedicine
8
ArticleCitations 1,7082018
Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 29 cancer groups, 2006 to 2016: A systematic analysis for the Global Burden of Disease study.Christina Fitzmaurice*
GeneticsBiochemistry, Genetics and Molecular Biology
9
ArticleCitations 1,4972020
Estrogen and Progesterone Receptor Testing in Breast Cancer: ASCO/CAP Guideline UpdateKimberly H. Allison, M. Elizabeth H. Hammond, Mitch Dowsett, Shannon McKernin, Lisa A. Carey, Patrick L. Fitzgibbons, Daniel F. Hayes, Sunil R. Lakhani, Mariana Chávez‐MacGregor, Jane Perlmutter, Charles M. Perou, Meredith M. Regan, David L. Rimm, W. Fraser Symmans, Emina Torlakovic, Leticia Varella, Giuseppe Viale, Tracey Weisberg, Lisa M. McShane, Antonio C. Wolff
OACancer ResearchBiochemistry, Genetics and Molecular Biology
10
ReviewCitations 1,4752019
Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: ASCO Clinical Practice Guideline UpdateNigel S. Key, Alok A. Khorana, Nicole M. Kuderer, Kari Bohlke, Agnes Lee, Juan I. Arcelus, Sandra L. Wong, Edward P. Balaban, Christopher R. Flowers, Charles W. Francis, Leigh E. Gates, Ajay K. Kakkar, Mark N. Levine, Howard A. Liebman, Margaret A. Tempero, Gary H. Lyman, Anna Falanga
OAInternal MedicineMedicine
11
ReviewCitations 1,4452018
Fertility Preservation in Patients With Cancer: ASCO Clinical Practice Guideline UpdateKutluk Oktay*, Brittany Harvey, Ann H. Partridge, Gwendolyn P. Quinn, Joyce Reinecke, Hugh S. Taylor, William H. Wallace, Erica T. Wang, Alison W. Loren
Public Health, Environmental and Occupational HealthMedicine
12
ArticleCitations 1,4242018
Practical Assessment and Management of Vulnerabilities in Older Patients Receiving Chemotherapy: ASCO Guideline for Geriatric OncologySupriya G. Mohile, William Dale, Mark R. Somerfield, Mara A. Schonberg, Cynthia M. Boyd, Peggy Burhenn, Beverly Canin, Harvey Jay Cohen, Holly M. Holmes, Judith O. Hopkins, Michelle C. Janelsins, Alok A. Khorana, Heidi D. Klepin, Stuart M. Lichtman, Karen M. Mustian, William P. Tew, Arti Hurria
OAGeriatrics and GerontologyMedicine
13
ArticleCitations 1,4212018
Molecular Determinants of Response to Anti–Programmed Cell Death (PD)-1 and Anti–Programmed Death-Ligand 1 (PD-L1) Blockade in Patients With Non–Small-Cell Lung Cancer Profiled With Targeted Next-Generation SequencingHira Rizvi, Francisco Sánchez-Vega, Konnor La, Walid K. Chatila, Philip Jonsson, Darragh Halpenny, Andrew J. Plodkowski, Niamh M. Long, Jennifer L. Sauter, Natasha Rekhtman, Travis J. Hollmann, Kurt A. Schalper, Justin F. Gainor, Ronglai Shen, Ai Ni, Kathryn C. Arbour, Taha Merghoub, Jedd D. Wolchok, Alexandra Snyder, Jamie E. Chaft, Mark G. Kris, Charles M. Rudin, Nicholas D. Socci, Michael F. Berger, Barry S. Taylor, Ahmet Zehir, David B. Solit, Maria E. Arcila, Marc Ladanyi, Gregory J. Riely, Nikolaus Schultz, Matthew D. Hellmann
OACancer ResearchBiochemistry, Genetics and Molecular Biology
14
ArticleCitations 1,3262018
Comparison of an Oral Factor Xa Inhibitor With Low Molecular Weight Heparin in Patients With Cancer With Venous Thromboembolism: Results of a Randomized Trial (SELECT-D)Annie Young, Andrea Marshall, Jenny Thirlwall, Oliver Chapman, Anand Lokare, Catherine St. Hill, Danielle Hale, Janet Dunn, Gary H. Lyman, Charles Hutchinson, Peter MacCallum, Ajay K. Kakkar, Richard Hobbs, Stavros Petrou, Jeremy Dale, Christopher Poole, Anthony Maraveyas, Mark N. Levine
OAInternal MedicineMedicine
15
ArticleCitations 1,2952022
Five-Year Survival Outcomes From the PACIFIC Trial: Durvalumab After Chemoradiotherapy in Stage III Non–Small-Cell Lung CancerDavid R. Spigel, Corinne Faivre-Finn, Jhanelle E. Gray, David Vicente, David Planchard, Luis Paz-Ares, Johan F. Vansteenkiste, Marina C. Garassino, Rina Hui, Xavier Quantin, Andreas Rimner, Yi-Long Wu, Mustafa Özgüroğlu, Ki H. Lee, Terufumi Kato, Maike de Wit, Takayasu Kurata, Martin Reck, Byoung C. Cho, Suresh Senan, Jarushka Naidoo, Helen Mann, Michael Newton, Piruntha Thiyagarajah, Scott J. Antonia
OAPulmonary and Respiratory MedicineMedicine
16
ArticleCitations 1,2702019
Local Consolidative Therapy Vs. Maintenance Therapy or Observation for Patients With Oligometastatic Non–Small-Cell Lung Cancer: Long-Term Results of a Multi-Institutional, Phase II, Randomized StudyDaniel R. Gomez, Chad Tang, Jianjun Zhang, George R. Blumenschein, Mike Hernández, J. Jack Lee, Rong Ye, David A. Palma, Alexander V. Louie, D. Ross Camidge, Robert C. Doebele, Ferdinandos Skoulidis, Laurie E. Gaspar, James W. Welsh, Don L. Gibbons, José A. Karam, Brian D. Kavanagh, Anne S. Tsao, Boris Sepesi, Stephen G. Swisher, John V. Heymach
OAPulmonary and Respiratory MedicineMedicine
17
ArticleCitations 1,2422020
Stereotactic Ablative Radiotherapy for the Comprehensive Treatment of Oligometastatic Cancers: Long-Term Results of the SABR-COMET Phase II Randomized TrialDavid A. Palma, Robert Olson, Stephen Harrow, Stewart Gaede, Alexander V. Louie, Cornelis J.A. Haasbeek, Liam Mulroy, Michael Lock, George Rodrigues, Brian Yaremko, Devin Schellenberg, Belal Ahmad, Sashendra Senthi, Anand Swaminath, Neil Kopek, Mitchell Liu, Karen Moore, Suzanne Currie, Roel Schlijper, Glenn Bauman, Joanna Laba, Xiaotao Qu, Andrew Warner, Suresh Senan
OAHepatologyMedicine
18
ArticleCitations 1,1862019
ARCHES: A Randomized, Phase III Study of Androgen Deprivation Therapy With Enzalutamide or Placebo in Men With Metastatic Hormone-Sensitive Prostate CancerAndrew J. Armstrong, Russell Z. Szmulewitz, Daniel P. Petrylak, Jeffrey M. Holzbeierlein, Arnauld Villers, Arun Azad, Antonio Alcaraz, B. Yа. Alekseev, Taro Iguchi, Neal D. Shore, Brad Rosbrook, Jennifer Sugg, Benoît Baron, Lucy Chen, Arnulf Stenzl
OAPulmonary and Respiratory MedicineMedicine
19
ArticleCitations 1,1852019
Five-Year Overall Survival for Patients With Advanced Non‒Small-Cell Lung Cancer Treated With Pembrolizumab: Results From the Phase I KEYNOTE-001 StudyEdward B. Garon, Matthew D. Hellmann, Naiyer A. Rizvi, Enric Carcereny, Natasha B. Leighl, Myung-Ju Ahn, Joseph Paul Eder, Ani S. Balmanoukian, Charu Aggarwal, Leora Horn, Amita Patnaik, Matthew Gubens, Suresh S. Ramalingam, Enriqueta Felip, Jonathan W. Goldman, Cathie Scalzo, Erin Jensen, Debra A. Kush, Rina Hui
OAOncologyMedicine
20
ArticleCitations 1,1762020
Randomized Phase III KEYNOTE-181 Study of Pembrolizumab Versus Chemotherapy in Advanced Esophageal CancerTakashi Kojima, Manish A. Shah, Kei Muro, Éric François, Antoine Adenis, Chih‐Hung Hsu, Toshihiko Doi, Toshikazu Moriwaki, Sung‐Bae Kim, Se‐Hoon Lee, Jaafar Bennouna, Ken Kato, Lin Shen, Peter C. Enzinger, Shukui Qin, Paula Ferreira, Jia Chen, Gustavo Girotto, Christelle de la Fouchardière, Hélène Senellart, Raed Moh’d Taiseer Al-Rajabi, Florian Lordick, Ruixue Wang, Shailaja Suryawanshi, Pooja Bhagia, Soonmo Peter Kang, Jean‐Philippe Metges, on behalf of the KEYNOTE-181 Investigators
SurgeryMedicine
Similar journals
Check your draft against this journal
Start free with Nubint AI — citation checks and a peer-review simulation.
Data as of 2026-09-05